Mycophenolate Mofetil
60 NDCs across 19 manufacturers|55 Generic,5 Brand
Mycophenolate Mofetil is used to treat graft vs host disease and psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 3, 1995, and the first generic was approved Jul 29, 2008. FDA's Orange Book lists 29 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $67 million on Mycophenolate Mofetil across 518,000 claims for 116,000 beneficiaries.
Mycophenolate Mofetil is available as 60 NDCs from 19 manufacturers (55 generic, 5 brand), with NADAC prices from $0.14 to $17.34 per EA — the most expensive product costs about 125× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
60
55G / 5B
Manufacturers
19
competing in market
Price Spread
$0.14 – $17.34
per EA, 53 of 60 NDCs
7d Activity
avg -0.6% WoW · of 60 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Genentech, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antimetabolite Immunosuppressant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
19 manufacturers producing MYCOPHENOLATE MOFETIL(4 pricing outliers)
Frequently Asked Questions
What is Mycophenolate Mofetil used to treat?
Mycophenolate Mofetil is used to treat graft vs host disease and psoriasis, per the National Library of Medicine's MED-RT classification.
When did Mycophenolate Mofetil become available as a generic?
FDA approved the first generic Mycophenolate Mofetil (ANDA) on Jul 29, 2008. The Orange Book currently lists 29 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Mycophenolate Mofetil?
In 2024, Medicare Part D spent $67 million on Mycophenolate Mofetil across 518,000 claims for 116,000 beneficiaries.
How many Mycophenolate Mofetil products are on the market?
The Mycophenolate Mofetil drug market contains 60 NDCs from 19 manufacturers — 55 generic and 5 brand products.
What is the price range for Mycophenolate Mofetil?
NADAC reference prices for Mycophenolate Mofetil range from $0.1382 to $17.3394 per EA — the most expensive product costs about 125× the cheapest. 7 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Mycophenolate Mofetil cheaper than brand?
The average generic NADAC for Mycophenolate Mofetil is $0.2001 per EA, versus $12.9942 for brand-labeled products — brand versions average about 65× the generic price.
Which manufacturers make Mycophenolate Mofetil?
19 manufacturers list Mycophenolate Mofetil in NADAC. Ranked by number of NDCs, the largest are Genentech, Inc. (5), Ascend Laboratories, LLC (5), Aurobindo Pharma Limited (5), Heritage Pharmaceuticals Inc. (5), Sandoz Inc. (5).
How has the price of Mycophenolate Mofetil changed recently?
Over the past 7 days, 8 Mycophenolate Mofetil NDCs rose and 47 fell, with a market-wide average change of -0.6%.